Aspire biopharma holdings, inc., announces public listing on nasdaq

New york city, ny / access newswire / february 19, 2025 / aspire biopharma, inc. ("aspire" or the "company"), a developer of a multi-faceted patent-protected disruptive drug delivery mechanism technology, and powerup acquisition corp. (nasdaq:pwup), a nasdaq global market® listed special purpose acquisition company, ("powerup"), today announced the completion of their previously announced business combination (the "business combination"). the business combination was approved by powerup acquisition corp. stockholders on january 31, 2025, and it closed on february 17, 2025.
NDAQ Ratings Summary
NDAQ Quant Ranking